کد مقاله | کد نشریه | سال انتشار | مقاله انگلیسی | نسخه تمام متن |
---|---|---|---|---|
8734249 | 1590946 | 2017 | 22 صفحه PDF | دانلود رایگان |
عنوان انگلیسی مقاله ISI
Low-cost matched sibling bone marrow transplant for standard-risk thalassemia in a limited-resource setting
ترجمه فارسی عنوان
پیوند مغز استخوان همراه با همسالان با هزینه پایین برای تالاسمی استاندارد خطر در تنظیم محدود منابع
دانلود مقاله + سفارش ترجمه
دانلود مقاله ISI انگلیسی
رایگان برای ایرانیان
کلمات کلیدی
تالاسمی، پیوند مغز استخوان، خطر استاندارد، کشور درآمد کم درآمد، هزینه مراقبت های بهداشتی،
موضوعات مرتبط
علوم پزشکی و سلامت
پزشکی و دندانپزشکی
هماتولوژی
چکیده انگلیسی
Thalassemias are the most common inherited genetic disorder in India and a major public health burden with bone marrow transplant (BMT) considered the only established curative therapy. We describe outcomes for patients (n = 71) with standard-risk thalassemia (liver size < 2 cm and age <15 years), receiving BMT in 6 low-cost start up BMT centers in the Indian sub-continent from August-2013 to July-2016. Patients received HLA-matched sibling donor unmanipulated BMT. Conditioning was with busulfan (14 mg/kg oral total over days â10 to â7, serum levels not measured), cyclophosphamide (200 mg/kg total over days â5 to â2) and anti-thymocyte globulin (Genzyme 4 mg/kg or Fresenius 16 mg/kg over days â12 to â10). Kaplan Meier survival analysis revealed thalassemia free survival (TFS) of 83% with overall survival (OS) of 93% with a median follow up of 17.5 months (IQR 13.4-22.6). Twelve percent of the patients rejected, 12% had severe GVHD (7% acute grade 3-4 GVHD and 4% had moderate/severe chronic GVHD). All 3 patients with acute GVHD Grade 3 are off immunosuppression, and those with chronic GVHD are well with Lansky score >80 at the last follow up. 5 patients (7%) died, mortality related to transplant. Enough data existed for 2 centers in India (36/71 transplants) to analyze overall costs from admission up to one-year post-BMT which revealed a median cost of Rs 7,30,445 ($11519) [Range Rs 4,52,821-10,32,842 ($ 7079-16147)]. In conclusion, children with thalassemia in resource limited settings can achieve good outcomes with BMT at a reasonable cost.
ناشر
Database: Elsevier - ScienceDirect (ساینس دایرکت)
Journal: Pediatric Hematology Oncology Journal - Volume 2, Issue 4, December 2017, Pages 107-113
Journal: Pediatric Hematology Oncology Journal - Volume 2, Issue 4, December 2017, Pages 107-113
نویسندگان
Stalin Ramprakash, Rajat Agarwal, Rakesh Dhanya, Priya Marwah, Rajpreet Soni, Naila Yaqub, Itrat Fatima, Tatheer Zhara, Lallindra Gooneratne, Senani Williams, Sadaf Khalid, Santanu Sen, Vikramjit Kanwar, Lawrence Faulkner,